Original Research
Accepted on 05 Feb 2026
Systems-Level Molecular and Immunological Evidence Identifies Th17/Treg Modulation as a Key Mechanism of CRSJ's Neuroprotection in Parkinson's Disease
in Parkinson’s Disease and Aging-related Movement Disorders